Erufosine
Erufosine is an inhibitor of the PI3K/Akt and Ras/Raf/MAPK signaling pathways. It suppresses the activity of breast cancer cell lines MCF-7 and MDA-MB 231 with an IC50 of 40.95/40.8 μM, respectively. Erufosine reduces phosphorylation of PI3K (p85), Akt (PKB), and cRaf, making it applicable in research on breast cancer and myeloid leukemia.
Product Specifications
CAS Number
202867-33-2
Field of Research
Signal Transduction
Smiles
P (OCCCCCCCCCCCC/C=C\CCCCCCCC) (OCCC[N+] (C) (C) C) (=O) [O-]
Molecular Formula
C28H58NO4P
Molecular Weight
503.74
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
VZB80856-01 100 mg
Ethyl 1-methyl-6-oxo-6,7-dihydro-1H-pyrazolo[3,4-b]pyridine-4-carboxylate
Sign In for Pricing
View Details VZB80856-02 1 g
Ethyl 1-methyl-6-oxo-6,7-dihydro-1H-pyrazolo[3,4-b]pyridine-4-carboxylate
Sign In for Pricing
View Details MBS1100590-01 0.02 mg (E-Coli)
Recombinant Sulfolobus islandicus Ribonuclease Z (rnz)
Sign In for Pricing
View Details MBS1100590-02 0.02 mg (Yeast)
Recombinant Sulfolobus islandicus Ribonuclease Z (rnz)
Sign In for Pricing
View Details